Literature DB >> 10654095

Neuropathology of Alzheimer's disease: what is new since A. Alzheimer?

E Braak1, K Griffing, K Arai, J Bohl, H Bratzke, H Braak.   

Abstract

Alzheimer's disease results from severe cytoskeletal alterations in only a few neuronal types within the human central nervous system. These intraneuronal changes take the form of neurofibrillary tangles and neuropil threads. Beginning in predisposed induction sites in the allocortex, the lesions follow a predictable sequence as they engulf other territories of the cerebral cortex and a specific set of subcortical nuclei. Some components of the brain are devastated, while others remain intact until the end phase of the disease. Assessment of the location of the afflicted neurons and the severity of the lesions allows the distinction of stages in the development of the disease. The degenerative process begins with the emergence of the first lesions, at whatever age it occurs. The illness remains subclinical for years, and proceeds inexorably, gradually laying waste to higher order limbic system centers. Clinical symptoms are observed only late in the course of the disease, and their appearance is usually concurrent with the encroachment of the destructive process upon neocortical association areas. The sequence of destruction bears a striking resemblance to the inverse sequence of cortical myelination. Late myelinating areas and layers develop the disease-related changes earlier and at higher densities than those which are myelinated early. The brain of the human adult is heavily laden with intraneuronal deposits of lipofuscin and neuromelanin pigment. The average density of neuronal pigmentation in given cortical areas mirrors the density of cytoskeletal lesions that develop in the course of the disease. Pigment-laden neuronal types giving rise to a single long, thin, unmyelinated or sparsely myelinated axon are particularly prone to developing Alzheimer's disease-related cytoskeletal changes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10654095     DOI: 10.1007/pl00014168

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  100 in total

Review 1.  In vivo brain imaging of tangle burden in humans.

Authors:  Gary W Small; Eric D Agdeppa; Vladimir Kepe; Nagichettiar Satyamurthy; Sung-Cheng Huang; Jorge R Barrio
Journal:  J Mol Neurosci       Date:  2002-12       Impact factor: 3.444

Review 2.  A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer's type: a neuroimaging profile.

Authors:  Konstantine K Zakzanis; Simon J Graham; Zachariah Campbell
Journal:  Neuropsychol Rev       Date:  2003-03       Impact factor: 7.444

3.  In vivo reduction of amyloid-beta by a mutant copper transporter.

Authors:  Amie L Phinney; Bettina Drisaldi; Stephen D Schmidt; Stan Lugowski; Veronica Coronado; Yan Liang; Patrick Horne; Jing Yang; Joannis Sekoulidis; Janaky Coomaraswamy; M Azhar Chishti; Diane W Cox; Paul M Mathews; Ralph A Nixon; George A Carlson; Peter St George-Hyslop; David Westaway
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-14       Impact factor: 11.205

4.  Neurobiology of delusions, memory, and insight in Alzheimer disease.

Authors:  David L Sultzer; Lorraine P Leskin; Rebecca J Melrose; Dylan G Harwood; Theresa A Narvaez; Timothy K Ando; Mark A Mandelkern
Journal:  Am J Geriatr Psychiatry       Date:  2013-09-08       Impact factor: 4.105

5.  N-PEP-12--a novel peptide compound that protects cortical neurons in culture against different age and disease associated lesions.

Authors:  M Windisch; B Hutter-Paier; E Grygar; E Doppler; H Moessler
Journal:  J Neural Transm (Vienna)       Date:  2005-03-07       Impact factor: 3.575

6.  Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease.

Authors:  Y Zhang; N Schuff; G-H Jahng; W Bayne; S Mori; L Schad; S Mueller; A-T Du; J H Kramer; K Yaffe; H Chui; W J Jagust; B L Miller; M W Weiner
Journal:  Neurology       Date:  2007-01-02       Impact factor: 9.910

7.  Too little, too late?

Authors:  Richard J Prettyman
Journal:  BMJ       Date:  2007-05-26

8.  Precuneus atrophy in early-onset Alzheimer's disease: a morphometric structural MRI study.

Authors:  Giorgos Karas; Philip Scheltens; Serge Rombouts; Ronald van Schijndel; Martin Klein; Bethany Jones; Wiesje van der Flier; Hugo Vrenken; Frederik Barkhof
Journal:  Neuroradiology       Date:  2007-10-23       Impact factor: 2.804

9.  A non-parametric approach for co-analysis of multi-modal brain imaging data: application to Alzheimer's disease.

Authors:  Satoru Hayasaka; An-Tao Du; Audrey Duarte; John Kornak; Geon-Ho Jahng; Michael W Weiner; Norbert Schuff
Journal:  Neuroimage       Date:  2006-01-10       Impact factor: 6.556

10.  The association between physical activity and dementia in an elderly population: the Rotterdam Study.

Authors:  Renée F A G de Bruijn; Elisabeth M C Schrijvers; Karen A de Groot; Jacqueline C M Witteman; Albert Hofman; Oscar H Franco; Peter J Koudstaal; Mohammad Arfan Ikram
Journal:  Eur J Epidemiol       Date:  2013-02-06       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.